Table 1.
Clinical profiles of the patients with kidney disease and healthy controls
| Parameter | Control, n=12 |
Minor, n=15 |
Minimal Change Nephrotic Syndrome, n=15 |
Membranous Nephropathy, n=15 |
IgA Nephropathy, n=60 |
Crescentic Glomerulonephritis, n=19 |
Lupus Nephritis, n=10 |
Others, n=38 |
|---|---|---|---|---|---|---|---|---|
| Age, yr | 34±5 | 45±18 | 54±18 | 65±16 | 41±15 | 65±15 | 40±16 | 54±15 |
| Sex, M/F | 1/11 | 9/6 | 7/8 | 6/9 | 24/36 | 10/9 | 1/9 | 18/20 |
| SBP, mm HG | N/A | 115±15 | 119±24 | 124±18 | 115±14 | 134±21 | 119±16 | 118±19 |
| DBP, mm HG | N/A | 71±12 | 72±14 | 71±12 | 71±11 | 74±11 | 76±11 | 70±14 |
| Serum Alb, g/dl | N/A | 4.0±0.6 | 1.5±0.3 | 2.3±0.7 | 3.9±0.5 | 2.9±0.7 | 2.7±0.6 | 3.2±0.9 |
| Serum Cre, mg/dl | N/A | 0.77±0.10 | 1.44±1.16 | 1.00±0.88 | 1.05±1.11 | 2.35±1.82 | 0.81±0.27 | 1.41±1.23 |
| eGFR, ml/min per 1.73 m2 | N/A | 81.3±18.9 | 51.7±27.8 | 67.2±25.7 | 70.9±25.5 | 33.8±26.4 | 74.2±24.5 | 52.6±25.1 |
| U-Pro/Cre, g/gCre | 0.04±0.03 | 0.30±0.46 | 6.69±5.38 | 3.42±2.83 | 0.71±1.14 | 1.76±2.25 | 2.23±1.18 | 2.62±3.22 |
| Drug use, % | ||||||||
| ARB or ACE-I | 0 | 26 | 7 | 40 | 22 | 26 | 40 | 34 |
| CCB | 0 | 13 | 27 | 60 | 18 | 58 | 30 | 47 |
| Immunosuppressives | 0 | 7 | 33 | 13 | 2 | 21 | 70 | 8 |
Values are given as means±SD or percentages. Minor, minor glomerular abnormality with mild proteinuria and/or microscopic hematuria; M, male; F, female; SBP, systolic BP; N/A, not applicable; DBP, diastolic BP; Alb, albumin; Cre, creatinine; U-pro/Cre, urinary protein to creatinine ratio; ARB, angiotensin receptor blocker; ACE-I, angiotensin-converting enzyme inhibitor; CCB, calcium channel blockers.